Charity Impact Media

Home › Diseases, disorders & medical disciplines

Barbara Ann Karmanos Cancer Hospital

Also known as Karmanos Cancer Center

Detroit, MI · EIN 20-1649466 · 501(c)(3) · Hospital or medical research organization
Latest filing: Form 990 for the fiscal year ending September 30, 2025 (tax year 2024) · View the filing · Correct or respond

Barbara Ann Karmanos Cancer Hospital reported $606.8 million in revenue and $551.1 million in expenses for the fiscal year ending September 30, 2025. Of every $100 it spent, $90.75 went to program services, $9.25 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 99.3% of the total. The highest compensation it reported for one person was $13,036,599 (BOARD MEMBER). 255 people received more than $100,000 in reportable compensation. Revenue rose 87% between FY2020 and FY2025. Source: Form 990, FY2025.

Where $100 of spending went

The fiscal year ending September 30, 2025 · Form 990, Part IX, line 25 · total expenses $551M

For context, the median across 314 covered diseases, disorders & medical disciplines charities: $88.73 programs, $10.89 management, $0.38 fundraising (medians computed separately, so they may not sum to $100).

Where $100 of revenue came from

The fiscal year ending September 30, 2025 · Form 990, Part VIII · total revenue $607M

The 990 scorecard · same measures for every charity, no grades

FY2025 filing. Median across 314 covered charities in this category, from their latest filings.
MeasureFY2025Median
Program services
Part IX 25(B) ÷ 25(A)
90.7%86.7%
Management & general
Part IX 25(C) ÷ 25(A)
9.3%10.6%
Fundraising
Part IX 25(D) ÷ 25(A)
0.0%0.4%
Fundraising cost per $1 of contributions
Part IX 25(D) ÷ Part VIII 1h
Not reported$0.03
Contributions & grants share of revenue
Part VIII 1h ÷ 12
0.0%24.7%
Government grants share of revenue
Part VIII 1e ÷ 12
0.0%0.6%
Program service revenue share
Part VIII 2g ÷ 12
99.3%59.5%
Highest reported compensation
Part VII-A, columns D–F
$13,036,599$391,657
Highest compensation as share of expenses
Part VII-A ÷ Part IX 25(A)
2.37%1.45%
People paid over $100,000
Part VII, line 2
25510
Net assets, in months of expenses
Part X 33(B) ÷ monthly expenses
1.87.6
Independent voting board members
Part VI 1a–1b
13 of 18100.0%

A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.

What the money paid for, in its own words

FY2025 · Form 990, Part III · the three largest programs by expense
$400M expenses · 80.0% of program spending · grants $463K · revenue $469M

Ambulatory services: the Barbara Ann Karmanos Cancer Hospital provided medical services to cancer patients including radiation oncology, chemotherapy, bone marrow transplant, mammography and hematology consultative, diagnostic and treatment services. Essential cancer and medical services are provided to the community. From october 2024 to september 2025, the following outpatient statistics were reported: clinical encounters 66,637; infusion patient encounters 34,405; imaging encounters 45,569; pheresis patient encounters 577; inpatient and outpatient radiation oncology encounters 25,325; and…

$76M expenses · 15.3% of program spending · grants $88,715 · revenue $104M

Inpatient: health care delivery & management: Barbara Ann Karmanos Cancer Hospital is dedicated to the delivery of cancer care services, the treatment and care of cancer patients and the prevention of cancer. Additionally, karmanos promotes, encourages, AIDS and performs scientific investigations and research addressing the cause, treatment and prevention of cancer. Essential cancer medical services are provided to the community. From october 2024 to september 2025, karmanos had 20,987 patient days and 2,359 discharges for an average length of stay of 8.90 days. In addition, there were 188…

$23M expenses · 4.7% of program spending · grants $40,711 · revenue $29M

The Barbara Ann Karmanos Cancer Hospital promotes AIDS and performs scientific investigations and research addressing the cause, treatments and prevention of cancer. For the period october 2024 to september 30, 2025, kcc had 4,249 phase 1 infusion patient visits, 265 active clinical drug trials; 297 patients willing to participate in clinical programs, and 483 eligible and registered participants

Highest reported compensation

FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here
RoleFrom this orgFrom related orgsOtherTotal
BOARD MEMBER
Director/trustee, 1.0 hrs/week
$0$12,956,846$79,753$13,036,599
PHYSICIAN MANAGER
Highest compensated employee, 40.0 hrs/week
$1,337,224$0$34,239$1,371,463
PHYSICIAN MANAGER
Highest compensated employee, 40.0 hrs/week
$1,329,696$0$17,264$1,346,960
PRESIDENT KCC
Director/trustee, officer, 41.0 hrs/week
$0$1,040,039$55,000$1,095,039
BOARD MEMBER/PRESIDENT KCI
Director/trustee, officer, 21.0 hrs/week
$0$735,782$18,785$754,567
PHYSICIAN MANAGER
Highest compensated employee, 40.0 hrs/week
$705,867$0$32,889$738,756
SERVICE CHIEF RADIOLOGY
Highest compensated employee, 40.0 hrs/week
$716,173$0$17,264$733,437
RADIOLOGIST
Highest compensated employee, 40.0 hrs/week
$658,621$0$32,937$691,558

255 people received more than $100,000 in reportable compensation from Barbara Ann Karmanos Cancer Hospital (Part VII, line 2). Compensation of current officers, directors and key employees totaled $2.0M (Part IX, line 5).

6 years of filings

Form 990, Parts I, VII, IX and X · each row is that year's own filing, linked
FilingRevenueExpensesProgramsNet assetsTop pay
FY2025 ⓘ$607M$551M90.7%$84M$13,036,599
FY2024 ⓘ$573M$509M89.8%$76M$11,859,773
FY2023 (amended) ⓘ$469M$435M90.9%$156M$10,783,704
FY2022 ⓘ$402M$378M88.0%$45M$9,891,147
FY2021 ⓘ$375M$354M83.4%$185M$8,756,201
FY2020 ⓘ$325M$304M86.0%$165M$8,155,554

Governance answers, as filed

FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means
  • Voting board members, and how many are independent Part VI, lines 1a–1b18 · 13 independent
  • Audited financial statements Part XII 2bYes
  • Conflict-of-interest policy Part VI 12aYes
  • Whistleblower policy Part VI 13Yes
  • Document retention policy Part VI 14Yes
  • Independent process for top executive pay Part VI 15aNo
  • Board given the 990 before filing Part VI 11aNo
  • Family or business ties among insiders Part VI 2No
  • Aware of a significant diversion of assets Part VI 5No
  • Excess benefit transaction with an insider Part IV 25aNo
  • Loans to or from insiders outstanding Part IV 26Yes
  • Lobbying, or a 501(h) election in effect Part IV 4Yes
  • Over $15,000 of professional fundraising services Part IV 18No
  • Over $10,000 of activity outside the U.S. Part IV 14bNo
  • Employees Part I, line 51,156
  • Volunteers Part I, line 613

Correct a figure or respond

Every number above is copied from Barbara Ann Karmanos Cancer Hospital's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Barbara Ann Karmanos Cancer Hospital, you can publish a response that is linked from this page.

Questions people ask

How much of Barbara Ann Karmanos Cancer Hospital's spending goes to programs?

In the fiscal year ending September 30, 2025, Barbara Ann Karmanos Cancer Hospital reported that 90.7% of its $551.1 million in expenses went to program services, 9.3% to management and general and 0.0% to fundraising (Form 990, Part IX).

How much does Barbara Ann Karmanos Cancer Hospital pay its top executive?

The largest total compensation Barbara Ann Karmanos Cancer Hospital reported for one person in the fiscal year ending September 30, 2025 was $13,036,599, for the role of BOARD MEMBER (Form 990, Part VII, including compensation from related organizations and other compensation).

Where does Barbara Ann Karmanos Cancer Hospital get its money?

Of $606.8 million in revenue in the fiscal year ending September 30, 2025, 0.0% came from contributions and grants and 99.3% from program service revenue (Form 990, Part VIII).

Is Barbara Ann Karmanos Cancer Hospital a registered charity?

The IRS lists EIN 20-1649466 as a 501(c)(3) organization (hospital or medical research organization), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.

Sources

  • FY2025: Form 990 for the fiscal year ending September 30, 2025, object 202632199349303653 · read the filing
  • FY2024: Form 990 for the fiscal year ending September 30, 2024, object 202542239349302184 · read the filing
  • FY2023: Form 990 for the fiscal year ending September 30, 2023 (amended), object 202510159349301276 · read the filing
  • FY2022: Form 990 for the fiscal year ending September 30, 2022, object 202332229349300933 · read the filing
  • FY2021: Form 990 for the fiscal year ending September 30, 2021, object 202242239349300929 · read the filing
  • FY2020: Form 990 for the fiscal year ending September 30, 2020, object 202142219349301039 · read the filing

All filings for EIN 20-1649466: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.